BioSpace News Archive

FDA-approved prescription drugs Lysodren® and Metopirone® in the United States

In an IND-enabling study, intranasal COVI-AMG nAb (STI-2099 or COVI-DROPSTM) very early on decreased COVID-19 disease severity and shortened the duration of the disease in infected hamsters

Natera, Inc., a pioneer and global leader in cell-free DNA testing, announced that a major health plan has extended coverage for non-invasive prenatal testing to all singleton pregnancies,1 representing 17 million additional covered lives.

- New executive brings strong legal experience serving as General Counsel for biopharmaceutical companies as Edgewise advances clinical muscular dystrophy program -

Financing to build on significant 2020 commercial momentum following the publication of 5-year data demonstrating the long-term clinical benefits of the Intracept Procedure

Preclinical Data Demonstrates MEB-1170 Lacks Dangerous Side Effects Including Respiratory Depression and Opioid Abuse Potential

Funding to advance Synaptive’s suite of fully automated cranial and spinal equipment and software designed to optimize personalized patient care

Littelfuse, Inc. (NASDAQ: LFUS), a global manufacturer of leading technologies in circuit protection, power control and sensing, announced today it will participate in the Baird Virtual Global Industrial Conference on November 10, 2020 and the Stifel Virtual Midwest One-on-One Growth Conference on November 11, 2020.

Sensus Healthcare, Inc., a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, November 5, 2020 at 4:30 p.m. Eastern time to discuss the financial results for the third quarter of 2020.

Agency-wide CRADA agreement also includes studies with Brain-Chip in Alzheimer’s disease, Intestine-Chip in microbiome health, and Liver-Chip in individualized toxicity responses